Next Post

Seattle startup raises $9.7M for clinical trial to test inhaled CBD as anxiety treatment

Receptor Life Sciences CEO Mark Theeuwes. (Receptor Image) Seattle startup Receptor Daily life Sciences has raised $9.7 million to shift its CBD-centered therapeutic applicant for acute panic by way of clinical screening. The organization is creating a dry powdered sort of cannabidiol (CBD) paired with an inhaler. The approach provides […]

Subscribe US Now